Hot off the Press

February 26, 2014

Diversity Alliance for Science appoints Anna Walz, CEO for MedEvoke, to its Board of Directors MedEvoke, a leading medical communications company with unique expertise in driving organizationally aligned scientific narrative development for biopharmaceutical companies, today announced the selection of its CEO, Anna Walz, to the Board of Directors for Diversity Alliance for Science. Effective February 27, 2014, Walz will begin serving a two-year term as Board member. As the CEO of a female-led, minority-owned, certified diverse supplier, Walz has grown MedEvoke from a small enterprise to one that is perceived by numerous top-10 pharmaceutical companies as an essential strategic partner in narrative development for products at all stages of the life cycle.

 

The Challenge

How will you reconcile competing goals, objectives, languages, cultures and budgets across the many organizational functions and regional affiliates?

The Solution

Why Align?

Every day a launch is delayed can cost your company $8MM
Inefficient clinical trials that fail to reflect a clear scientific narrative cost the industry $4-6B annually

Get Aligned

Our website is protected by DMC Firewall!